Meeting
2022 ASCO Annual Meeting
Retrospective review of outcomes of patients with multiple myeloma with COVID-19 infection (two-center study).
Authors
Hamid Ehsan
Levine Cancer Institute, Atrium Health, Charlotte, NC
Hamid Ehsan , Alec Britt , Peter M. Voorhees , Barry Paul , Manisha Bhutani , Cindy Varga , Zane Chiad , Brittany K. Ragon , Zainab Shahid , Moussa Shahoud , Al-Ola A. Abdallah , Nausheen Ahmed , Shebli Atrash
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8048)
DOI
10.1200/JCO.2022.40.16_suppl.8048
Abstract #
8048
Poster Bd #
472
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Patient navigation plus hospital at home to improve COVID-19 outcomes for cancer patients.
First Author: Brittany K. Ragon
Poster
2024 ASCO Breakthrough
Mortality and economic cost in common primary cancer admitted with COVID-19: Analysis of NIS 2020.
First Author: Thanathip Suenghataiphorn
Poster
2023 ASCO Annual Meeting
A phase 2 evaluation of daratumumab-based induction therapy in patients with multiple myeloma with severe renal insufficiency.
First Author: R. Donald Harvey
Poster
2023 ASCO Annual Meeting
Impact of SARS-COV2 infection on the clinical outcomes in patients with lung cancer compared to all other cancers.
First Author: Vaishali Deenadayalan